JM Giltnane, MD, PhD

520 posts

JM Giltnane, MD, PhD banner
JM Giltnane, MD, PhD

JM Giltnane, MD, PhD

@labmedpath

🧬Physician-scientist 🤖 computational pathology 🚀spatial biology👩🏻‍🔬cancer research 🔬 diagnostic tissue assays

San Francisco, CA Katılım Şubat 2010
629 Takip Edilen587 Takipçiler
JM Giltnane, MD, PhD
JM Giltnane, MD, PhD@labmedpath·
When I started working in science, HER2+ breast cancer had the worst prognosis. Targeted therapies turned that around and many patients show complete response to neoadjuvant combos. Truly honored to work at Genentech with Gail and others that made these l…lnkd.in/gTyQaCwF
English
0
0
0
101
JM Giltnane, MD, PhD
JM Giltnane, MD, PhD@labmedpath·
Really grateful for the time to travel to Boston and the connections made while there! I enjoyed the panel with @PathAI and the opportunity to wave my “Let’s transform Pathology!” flag. lnkd.in/gARdbKXf
English
0
0
0
0
JM Giltnane, MD, PhD
JM Giltnane, MD, PhD@labmedpath·
We're hiring! lnkd.in/gTBfMvdQ Digital & Spatial Pathology section of Genentech Research & Early Development is hiring a pathologist and/or scientist. The position will be focused on enabling the digital transformation of our pathology strategies,…lnkd.in/gXNrXmZf
English
0
0
2
0
JM Giltnane, MD, PhD
JM Giltnane, MD, PhD@labmedpath·
Digital pathology experts: what ontology standards are you utilizing?
English
0
0
0
0
JM Giltnane, MD, PhD
JM Giltnane, MD, PhD@labmedpath·
Genentech's Translational Tissue Technology (T3) lab collaborated with Hartmut Koeppen Namrata Srivastava Patil and others on this manuscript, investigating the role of plasma cells and tertiary lymphoid structures in #immunotherapy Join our team! We ar…lnkd.in/gNnFg5n8
English
0
0
1
0
JM Giltnane, MD, PhD
JM Giltnane, MD, PhD@labmedpath·
The Translational Tissue Technology lab strives to stay ahead of the curve so Genentech scientists have access to the best #technology platforms for generating biological insights and developing the best drugs for our patients. Most of these technologies…lnkd.in/gBsYMSWh
English
0
0
0
0
JM Giltnane, MD, PhD
JM Giltnane, MD, PhD@labmedpath·
Great to see these results, demonstrating how AI/ML in pathology that can produce readouts augmenting clinical interpretation of histologic endpoints & impact patient care for NASH! lnkd.in/g4qUfyMw
English
0
0
0
0
JM Giltnane, MD, PhD retweetledi
Genentech
Genentech@genentech·
A deeper understanding of how immune cells interact with tumors can help inform future cancer immunotherapies. In @Cancer_Cell, our scientists Milena Hornburg, Yulei Wang & team describe new biological underpinnings that characterize these interactions. bit.ly/3b5WsHK
English
0
4
15
0
JM Giltnane, MD, PhD retweetledi
Julia Maués
Julia Maués@itsnot_pink·
“What do patients w/ cancer want from their oncologists?” I know! 👉 Be like @DrEricWiner! This wonderful doctor makes even a talk on end of life conversations a lovely one! To a mostly empty room at #sabcs19, he says “the people that are not here definitely should be”.
Julia Maués tweet media
English
4
40
170
0
JM Giltnane, MD, PhD retweetledi
Jane
Jane@DrJaneCocks·
APA welcomes singular “they” ~ "Writers should use singular “they”: (a) when referring to a generic person whose gender is unknown or irrelevant to the context and (b) when referring to a specific, known person who uses “they” as their pronoun." apastyle.apa.org/blog/singular-…
English
128
12.5K
33.2K
0